Print

Regulus Therapeutics, Inc. Reports Second Quarter 2013 Financial Results and Recent Highlights  
8/14/2013 6:19:37 AM

Regeneron may be hiring! Check it out! (Isn't it tempting?)

LA JOLLA, Calif., Aug. 13, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the quarter ended June 30, 2013 and provided a summary of recent corporate highlights.

Help employers find you! Check out all the jobs and post your resume.

//-->